IIL is ready to roll out Bharat Biotech’s Covaxin drug substance by July-August
Indian Immunological Limited (IIL) is a name that may have been heard by some outside the vaccine industry. But the vaccine manufacturer hopes to play an important role in Bharat Biotech’s ambitious plan, which will increase production of covaxin to 700 million doses annually. IIL executive officers are overdue to revive the newly built manufacturing …
IIL is ready to roll out Bharat Biotech’s Covaxin drug substance by July-August Read More »